Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Caitlin E. Cox

May 24, 2023

News Conference News EuroPCR 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

Shelley Wood

May 16, 2023

News Features

ChatGPT et al? Not So Fast, Say Journal Editors

Yael L. Maxwell

April 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

Caitlin E. Cox

August 03, 2020

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Conference News EuroPCR 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Caitlin E. Cox

May 16, 2017

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Daily News

Los Valores FFR en Lesiones Intermedias se ven Influidos por una Respuesta Exagerada a la Adenosina

January 15, 2014

News Daily News

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

January 15, 2014

News Industry News

Trial Examines Benefits of Using a New Test to Determine the Severity of Coronary Artery Disease

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

News Industry News

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

October 29, 2013

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

Advertisement

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

INOCA May Be at the Root of Angina for Many Long-COVID Patients

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

ChatGPT et al? Not So Fast, Say Journal Editors

TCTMD’s Top 10 Most Popular Stories for August 2020

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Los Valores FFR en Lesiones Intermedias se ven Influidos por una Respuesta Exagerada a la Adenosina

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

Trial Examines Benefits of Using a New Test to Determine the Severity of Coronary Artery Disease

Novel Ischemia Measurement Strategies Show Potential vs. FFR

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content